Since HMGB1 was found to be elevated in inflammatory and infectious diseases as well, we recorded corresponding CRP levels (n = 61) and data on infections (n = 53) and treatment-associated toxicity (n = 58) during therapy. Here, CRP is linked to infectious disease.